Disease propagation in amyotrophic lateral sclerosis (ALS): an interplay between genetics and environment
Open Access
- 6 June 2020
- journal article
- review article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 17 (1) , 1-7
Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive, fatal disease affecting the neuromuscular system. While there have been a number of important genetic discoveries, there are no therapeutics capable of stopping its insidious progression. Lessons from clinical histories reveal that ALS can start focally at a single limb, but then segmentally spread up and down the spinal cord as well as in the motor cortex and cortex of frontal and temporal lobes until respiratory muscles fail. With or without a clear genetic etiology, often there is no explanation as to why it starts in one region of the body versus another. Similarly, once the disease starts the mechanisms by which the neurodegenerative process spreads are not known. Here, we summarize recent work in animal models that support the hypothesis that critical environmental contributions, such as a nerve injury, can initiate the disease process. We also propose that pathological axoglial signaling by the glial growth factor neuregulin-1 leads to the slow propagation of neuroinflammation resulting in neurodegeneration up and down the spinal cord and that locally applied drugs that block neuregulin-1 signaling could slow or halt the spread of disease.Keywords
This publication has 69 references indexed in Scilit:
- Genetics of amyotrophic lateral sclerosis: an updateMolecular Neurodegeneration, 2013
- Aberrant Neuregulin 1 Signaling in Amyotrophic Lateral SclerosisJournal of Neuropathology & Experimental Neurology, 2012
- Following nerve injury neuregulin‐1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathwayGlia, 2011
- Peripheral hyperstimulation alters site of disease onset and course in SOD1 ratsNeurobiology of Disease, 2010
- Targeting Human Epidermal Growth Factor Receptor Signaling with the Neuregulin's Heparin-binding DomainJournal of Biological Chemistry, 2009
- Mutant SOD1 G93A microglia have an inflammatory phenotype and elevated production of MCP-1NeuroReport, 2009
- Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouseHuman Molecular Genetics, 2009
- Neuregulin 1 in neural development, synaptic plasticity and schizophreniaNature Reviews Neuroscience, 2008
- Head Injury and Amyotrophic Lateral SclerosisAmerican Journal of Epidemiology, 2007
- Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosisProceedings of the National Academy of Sciences, 2006